Cronos Stock Pops on Renewed Optimism After Delayed Earnings
Cronos stock is soaring today after analysts at MKM Partners upgraded Cronos Group (TSX:CRON) (NASDAQ:CRON) from 'neutral' to 'buy', despite the company delaying the release of its earnings report last week. Earnings Delay Cronos Group ... [Read]
Organigram Stock Gains on New Leadership Appointments
Organigram stock is making gains today after Organigram Holdings (TSX:OGI) (NASDAQ:OGI) announced two new appointments to the positions of Chief Strategy Officer and Chief Financial Officer. The Moncton-based pot producer said in a March 4 ... [Read]
Will CannTrust Stock Be Able to Regain Compliance with the NYSE?
CannTrust stock continues to trade weakly this week after CannTrust Holdings (TSX:TRST) (NYSE:CTST) got a notice from the New York Stock Exchange on Friday. Non-Compliant Reminder Canadian cannabis producer CannTrust has been in all sorts ... [Read]
Aurora Stock Continues to Hit New Lows Amid Growing Pessimism
Over the past few years, a handful of companies have emerged that had the potential to end up being one of the leaders of the cannabis industry and Aurora Cannabis (TSX:ACB) (NYSE:ACB) was one of ... [Read]
CGC Stock Drops Despite Agreeing to Israeli Medical Deal
CGC stock is in the red today despite an announcement that Canopy Growth (TSX:WEED) (NYSE:CGC) had entered into a memorandum of understanding with Israeli firm Univo Pharmaceuticals for the sale, production, and marketing of medical ... [Read]
Aphria Stock Could Gain Momentum on Soaring German Demand
After a disastrous 2019, which saw Aphria stock fall by more than half, soaring demand in the German market could be a catalyst for growth for the troubled pot stock. Earnings Disappointment It's been over ... [Read]
Cresco Stock Tanks as President Leaves the Company
Cresco stock tanked this morning after Cresco Labs Inc (CSE:CL) (OTCQX:CRLBF) said that the company's President, Joe Caltabiano, is leaving the cannabis firm. Major Setback A lot is happening at the executive level of many ... [Read]
MedMen Stock Continues to Fall After Poor Earnings Performance
MedMen Enterprises (CSE:MMEN) (OTCQX:MMNFF) has been in trouble for quite some time, and the disappointment with the company’s recent fiscal second-quarter financial results has resulted in another selloff in MedMen stock. Disappointing Earnings MedMen is ... [Read]
Tilray Stock Drops as Analysts Predict Widening Loss: Earnings Released
Tilray stock is in the red today as the company prepares to post its fourth-quarter earnings after hours on March 2, with analysts expecting to see a sizeable rise in revenue despite a widening loss. ... [Read]
Organigram Stock Makes a Solid Case for Big Gains in 2.0 Market
Organigram stock is making gains on Monday as the Canadian cannabis producer looks to the legalization 2.0 market to help transform its fortunes after a disappointing year in 2019. After a difficult first year of ... [Read]